MedTrace Logo

OREIOS International Study

NCT05239507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1127

Last updated 2024-03-13

No results posted yet for this study

Summary

Considering the treatment landscape with its dynamic algorithms and new approaches of sequencing, it is important to identify patient management patterns and survival outcomes arising from the current standard of care. Based on all these considerations, this multicountry, multicentre, noninterventional, real-world, retrospective study is designed to describe the management patterns, clinical characteristics, possible predictors, and survival outcomes in patients with unresectable HCC. The results of this study might help oncologists in optimal patient selection and sequencing of the systemic therapies.

Conditions

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-03-12
Completion
2023-03-12

Countries

  • Brazil
  • Egypt
  • Hong Kong
  • India
  • Kuwait
  • Oman
  • Russia
  • Saudi Arabia
  • Singapore
  • South Korea
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05239507 on ClinicalTrials.gov